This award honors Tibor Greenwalt, MD, who was the first registrant at the first AABB Annual Meeting and founding editor of Transfusion. The award recognizes an individual who made major scientific or clinical contributions to hematology, transfusion medicine or biotherapies, and succinctly communicated these advances. Acceptance of this award requires attendance at the AABB Annual Meeting and the presentation of a lecture on a current topic of interest. Recipient will receive a $1,000 honorarium.
The Tibor Greenwalt Memorial Award and Lectureship is presented annually and the recipient is chosen one year in advance. This award is funded through an endowment from Dr. Peter Greenwalt.
To be eligible for this award, candidates:
Recipient is selected by a joint committee composed of leaders from the Cellular Therapies Section Coordinating Committee and the Transfusion Medicine Section Coordinating Committee with formal approval by AABB's Board of Directors.
Please send all inquiries about this award to awards@aabb.org.
James C. Zimring, MD, PhD
In recognition of his vast influence on the field and his scientific achievements. Dr. Zimring was among the first to use murine models extensively to study transfusion-based alloimmunization to red blood cells, hemolytic transfusion reactions and mechanisms of immunoprophylaxis of anti-D. These models have since been used throughout the field and have been indispensable in spurring further developments and leading to improvements in blood safety worldwide.
On-Demand Annual Meeting Sessions Available Through Nov. 21
October 30, 2024
Next Global Transfusion Webcast to Focus on Compatibility and Pretransfusion Practice
October 29, 2024
AABB24: Book Launch: Getting Started in Processing for Biotherapies
October 20, 2024